{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:10:05Z","timestamp":1790838605345,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jaip.2019.02.018","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T03:02:13Z","timestamp":1551236533000},"page":"1958-1969.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":184,"title":["Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review"],"prefix":"10.1016","volume":"7","author":[{"given":"Alexandre","family":"Fabre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Barlogis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Barbry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Simon","family":"Rohrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphanie P.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Giovannini-Chami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2019.02.018_bib1","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2019.02.018_bib2","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.02.018_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10875-015-0187-8","article-title":"The ying and yang of STAT3 in human disease","volume":"35","author":"Vogel","year":"2015","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2019.02.018_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2019.02.018_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaip.2019.02.018_bib6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2019.02.018_bib7","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.02.018_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2019.02.018_bib9","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1212\/NXG.0000000000000163","article-title":"ExACtly zero or once: a clinically helpful guide to assessing genetic variants in mild epilepsies","volume":"3","author":"Bennett","year":"2017","journal-title":"Neurol Genet"},{"key":"10.1016\/j.jaip.2019.02.018_bib10","doi-asserted-by":"crossref","first-page":"20037","DOI":"10.18632\/oncotarget.5042","article-title":"A\u00a0novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation","volume":"6","author":"Wienke","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaip.2019.02.018_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","article-title":"Genetic diagnosis using whole exome sequencing in common variable immunodeficiency","volume":"7","author":"Maffucci","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2019.02.018_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1182\/blood-2014-11-610592","article-title":"STAT3: too much may be worse than not enough!","volume":"125","author":"Haddad","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2019.02.018_bib13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1513\/AnnalsATS.201601-079OC","article-title":"Pulmonary manifestations of the autoimmune lymphoproliferative syndrome. A retrospective study of a unique patient cohort","volume":"13","author":"Lau","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2019.02.018_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.clinthera.2017.01.004","article-title":"Tocilizumab promotes regulatory T-cell alleviation in STAT3 gain-of-function\u2013associated multi-organ autoimmune syndrome","volume":"39","author":"Khoury","year":"2017","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaip.2019.02.018_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fped.2017.00049","article-title":"Up, down, and all around: diagnosis and treatment of novel STAT3 variant","volume":"5","author":"Weinreich","year":"2017","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2019.02.018_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000456544","article-title":"Short stature in a boy with multiple early-onset autoimmune conditions due to a STAT3 activating mutation: could intracellular growth hormone signalling be compromised?","volume":"88","author":"Sediva","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.jaip.2019.02.018_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clim.2017.05.021","article-title":"STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds","volume":"181","author":"Nabhani","year":"2017","journal-title":"Clin Immunol Orlando Fla"},{"key":"10.1016\/j.jaip.2019.02.018_bib18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2337\/db16-0867","article-title":"An activating mutation in STAT3 results in neonatal diabetes through reduced insulin synthesis","volume":"66","author":"Velayos","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jaip.2019.02.018_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2017.12.009","article-title":"Pediatric-onset Evans syndrome: heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations","volume":"188","author":"Besnard","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2019.02.018_bib20","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1164\/rccm.201707-1500IM","article-title":"STAT3 GOF: a new kid on the block in interstitial lung diseases","volume":"197","author":"Fabre","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.02.018_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.mce.2018.01.016","article-title":"Partial growth hormone insensitivity and dysregulatory immune disease associated with de novo germline activating STAT3 mutations","volume":"473","author":"Guti\u00e9rrez","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jaip.2019.02.018_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.clim.2017.11.007","article-title":"A\u00a0novel de novo activating mutation in STAT3 identified in a patient with common variable immunodeficiency (CVID)","volume":"187","author":"Russell","year":"2018","journal-title":"Clin Immunol Orlando Fla"},{"key":"10.1016\/j.jaip.2019.02.018_bib23","doi-asserted-by":"crossref","first-page":"e26831","DOI":"10.1002\/pbc.26831","article-title":"Genetic heterogeneity of uncharacterized childhood autoimmune diseases with lymphoproliferation","volume":"65","author":"Takagi","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaip.2019.02.018_bib24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/rheumatology\/key308","article-title":"STAT3 gain of function: a new aetiology of severe rheumatic disease","volume":"58","author":"Giovannini-Chami","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaip.2019.02.018_bib25","first-page":"508","article-title":"Collagenous colitis in children: clinicopathologic, microbiologic, and immunologic features","volume":"37","author":"Camarero","year":"2003","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaip.2019.02.018_bib26","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2019.02.018_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2015.09.025","article-title":"The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency","volume":"137","author":"G\u00e1mez-D\u00edaz","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.02.018_bib28","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.02.018_bib29","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","article-title":"A\u00a0survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation","volume":"118","author":"Neven","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2019.02.018_bib30","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.02.018_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ghir.2015.12.006","article-title":"STAT5B deficiency: impacts on human growth and immunity","volume":"28","author":"Hwa","year":"2016","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.jaip.2019.02.018_bib32","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2019.02.018_bib33","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa022926","article-title":"Growth hormone insensitivity associated with a STAT5b mutation","volume":"349","author":"Kofoed","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.02.018_bib34","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ajpath.2011.12.022","article-title":"STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP\/IPF","volume":"180","author":"Pechkovsky","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaip.2019.02.018_bibE1","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2019.02.018_bibE2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2019.02.018_bibE3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2019.02.018_bibE4","doi-asserted-by":"crossref","first-page":"20037","DOI":"10.18632\/oncotarget.5042","article-title":"A\u00a0novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation","volume":"6","author":"Wienke","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaip.2019.02.018_bibE5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","article-title":"Genetic diagnosis using whole exome sequencing in common variable immunodeficiency","volume":"7","author":"Maffucci","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2019.02.018_bibE6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1513\/AnnalsATS.201601-079OC","article-title":"Pulmonary manifestations of the autoimmune lymphoproliferative syndrome. A retrospective study of a unique patient cohort","volume":"13","author":"Lau","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2019.02.018_bibE7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.clim.2017.11.007","article-title":"A\u00a0novel de novo activating mutation in STAT3 identified in a patient with common variable immunodeficiency (CVID)","volume":"187","author":"Russell","year":"2018","journal-title":"Clin Immunol Orlando Fla"},{"key":"10.1016\/j.jaip.2019.02.018_bibE8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2337\/db16-0867","article-title":"An activating mutation in STAT3 results in neonatal diabetes through reduced insulin synthesis","volume":"66","author":"Velayos","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jaip.2019.02.018_bibE9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000456544","article-title":"Short stature in a boy with multiple early-onset autoimmune conditions due to a STAT3 activating mutation: could intracellular growth hormone signalling be compromised?","volume":"88","author":"Sediva","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.jaip.2019.02.018_bibE10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clim.2017.05.021","article-title":"STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds","volume":"181","author":"Nabhani","year":"2017","journal-title":"Clin Immunol Orlando Fla"},{"key":"10.1016\/j.jaip.2019.02.018_bibE11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.clinthera.2017.01.004","article-title":"Tocilizumab promotes regulatory T-cell alleviation in STAT3 gain-of-function\u2013associated multi-organ autoimmune syndrome","volume":"39","author":"Khoury","year":"2017","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaip.2019.02.018_bibE12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fped.2017.00049","article-title":"Up, down, and all around: diagnosis and treatment of novel STAT3 variant","volume":"5","author":"Weinreich","year":"2017","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2019.02.018_bibE13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.mce.2018.01.016","article-title":"Partial growth hormone insensitivity and dysregulatory immune disease associated with de novo germline activating STAT3 mutations","volume":"473","author":"Guti\u00e9rrez","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jaip.2019.02.018_bibE14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2017.12.009","article-title":"Pediatric-onset Evans syndrome: heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations","volume":"188","author":"Besnard","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2019.02.018_bibE15","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1164\/rccm.201707-1500IM","article-title":"STAT3 GOF: a new kid on the block in interstitial lung diseases","volume":"197","author":"Fabre","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.02.018_bibE16","doi-asserted-by":"crossref","first-page":"e26831","DOI":"10.1002\/pbc.26831","article-title":"Genetic heterogeneity of uncharacterized childhood autoimmune diseases with lymphoproliferation","volume":"65","author":"Takagi","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaip.2019.02.018_bibE17","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.02.018_bibE18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/rheumatology\/key308","article-title":"STAT3 gain of function: a new aetiology of severe rheumatic disease","volume":"58","author":"Giovannini-Chami","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaip.2019.02.018_bibE19","first-page":"508","article-title":"Collagenous colitis in children: clinicopathologic, microbiologic, and immunologic features","volume":"37","author":"Camarero","year":"2003","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819301941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819301941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:22:00Z","timestamp":1761974520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219819301941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S2213219819301941"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2019.02.018","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2019.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}